Logo image of AQNB

ALGONQUIN PWR & UTILITY - AQNCN 8.48669 07/01/2079 (AQNB) Stock Fundamental Analysis

NYSE:AQNB - New York Stock Exchange, Inc. - US0158578080 - Currency: USD

25.29  +0.04 (+0.16%)

Fundamental Rating

3

Overall AQNB gets a fundamental rating of 3 out of 10. We evaluated AQNB against 25 industry peers in the Multi-Utilities industry. AQNB has a medium profitability rating, but doesn't score so well on its financial health evaluation. AQNB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AQNB had positive earnings in the past year.
AQNB had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AQNB reported negative net income in multiple years.
AQNB had a positive operating cash flow in each of the past 5 years.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

AQNB has a worse Return On Assets (-9.49%) than 96.00% of its industry peers.
AQNB has a Return On Equity of -27.63%. This is amonst the worse of the industry: AQNB underperforms 96.00% of its industry peers.
AQNB has a Return On Invested Capital (3.93%) which is comparable to the rest of the industry.
AQNB had an Average Return On Invested Capital over the past 3 years of 2.36%. This is in line with the industry average of 3.92%.
The last Return On Invested Capital (3.93%) for AQNB is above the 3 year average (2.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -9.49%
ROE -27.63%
ROIC 3.93%
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

AQNB has a Operating Margin (21.00%) which is in line with its industry peers.
AQNB's Operating Margin has declined in the last couple of years.
AQNB has a Gross Margin of 73.47%. This is in the better half of the industry: AQNB outperforms 76.00% of its industry peers.
In the last couple of years the Gross Margin of AQNB has remained more or less at the same level.
Industry RankSector Rank
OM 21%
PM (TTM) N/A
GM 73.47%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AQNB is destroying value.
AQNB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AQNB has more shares outstanding
The debt/assets ratio for AQNB has been reduced compared to a year ago.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

AQNB has an Altman-Z score of 1.39. This is a bad value and indicates that AQNB is not financially healthy and even has some risk of bankruptcy.
AQNB's Altman-Z score of 1.39 is amongst the best of the industry. AQNB outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 1.28 is on the high side and indicates that AQNB has dependencies on debt financing.
AQNB's Debt to Equity ratio of 1.28 is fine compared to the rest of the industry. AQNB outperforms 64.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Altman-Z 1.39
ROIC/WACC0.58
WACC6.83%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

AQNB has a Current Ratio of 1.16. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
AQNB has a Current ratio of 1.16. This is amongst the best in the industry. AQNB outperforms 84.00% of its industry peers.
AQNB has a Quick Ratio of 1.16. This is a bad value and indicates that AQNB is not financially healthy enough and could expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 0.97, AQNB belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.97
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

AQNB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.49%.
Measured over the past years, AQNB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.38% on average per year.
AQNB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.38%.
The Revenue has been growing slightly by 7.38% on average over the past years.
EPS 1Y (TTM)-24.49%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%0%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-6.06%

3.2 Future

AQNB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.86% yearly.
The Revenue is expected to grow by 0.82% on average over the next years.
EPS Next Y-20.16%
EPS Next 2Y-0.53%
EPS Next 3Y0.93%
EPS Next 5Y2.86%
Revenue Next Year-9.8%
Revenue Next 2Y-3.24%
Revenue Next 3Y-0.5%
Revenue Next 5Y0.82%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 68.35, AQNB can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 92.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of AQNB to the average of the S&P500 Index (26.32), we can say AQNB is valued expensively.
The Price/Forward Earnings ratio is 69.07, which means the current valuation is very expensive for AQNB.
AQNB's Price/Forward Earnings ratio is rather expensive when compared to the industry. AQNB is more expensive than 96.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, AQNB is valued quite expensively.
Industry RankSector Rank
PE 68.35
Fwd PE 69.07
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 96.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.85
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.53%
EPS Next 3Y0.93%

6

5. Dividend

5.1 Amount

AQNB has a Yearly Dividend Yield of 4.53%, which is a nice return.
Compared to an average industry Dividend Yield of 4.23, AQNB pays a bit more dividend than its industry peers.
AQNB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 4.53%

5.2 History

The dividend of AQNB has a limited annual growth rate of 0.06%.
AQNB has been paying a dividend for over 5 years, so it has already some track record.
AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of AQNB are negative and hence is the payout ratio. AQNB will probably not be able to sustain this dividend level.
AQNB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-20.99%
EPS Next 2Y-0.53%
EPS Next 3Y0.93%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

25.29

+0.04 (+0.16%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners72.96%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.42B
Analysts67.69
Price Target20.45 (-19.14%)
Short Float %0%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield 4.53%
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-20.99%
Div Incr Years1
Div Non Decr Years4
Ex-Date06-13 2025-06-13 (0.5475)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.21%
Min EPS beat(2)-25.74%
Max EPS beat(2)42.17%
EPS beat(4)2
Avg EPS beat(4)3.68%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)3
Avg EPS beat(8)-2.73%
EPS beat(12)5
Avg EPS beat(12)-3.23%
EPS beat(16)6
Avg EPS beat(16)-2.32%
Revenue beat(2)1
Avg Revenue beat(2)0.35%
Min Revenue beat(2)-4.61%
Max Revenue beat(2)5.31%
Revenue beat(4)1
Avg Revenue beat(4)-1.14%
Min Revenue beat(4)-5.17%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-2.03%
Revenue beat(12)7
Avg Revenue beat(12)0.37%
Revenue beat(16)10
Avg Revenue beat(16)2.48%
PT rev (1m)5.61%
PT rev (3m)-5.01%
EPS NQ rev (1m)-12.49%
EPS NQ rev (3m)-11.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.72%
Valuation
Industry RankSector Rank
PE 68.35
Fwd PE 69.07
P/S 6.45
P/FCF N/A
P/OCF 45.7
P/B 4.14
P/tB 5.87
EV/EBITDA 23.85
EPS(TTM)0.37
EY1.46%
EPS(NY)0.37
Fwd EY1.45%
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)0.55
OCFY2.19%
SpS3.92
BVpS6.11
TBVpS4.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.49%
ROE -27.63%
ROCE 4.97%
ROIC 3.93%
ROICexc 3.95%
ROICexgc 4.44%
OM 21%
PM (TTM) N/A
GM 73.47%
FCFM N/A
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexcg growth 3Y4.3%
ROICexcg growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score5
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Debt/EBITDA 5.61
Cap/Depr 199.46%
Cap/Sales 29.3%
Interest Coverage 1.53
Cash Conversion 39.53%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.97
Altman-Z 1.39
F-Score5
WACC6.83%
ROIC/WACC0.58
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.49%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%0%
EPS Next Y-20.16%
EPS Next 2Y-0.53%
EPS Next 3Y0.93%
EPS Next 5Y2.86%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-6.06%
Revenue Next Year-9.8%
Revenue Next 2Y-3.24%
Revenue Next 3Y-0.5%
Revenue Next 5Y0.82%
EBIT growth 1Y26.92%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year44.64%
EBIT Next 3Y17.99%
EBIT Next 5YN/A
FCF growth 1Y-3.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.77%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%